Everwell Recovery Introduces New Resource Clarifying MAT, MOUD and Medication-Based Addiction Care

MISSION VIEJO, CA – October 09, 2026 – PRESSADVANTAGE –

Everwell Recovery has published a new educational resource explaining how medications may be incorporated into treatment for opioid and alcohol use disorders. The resource, “Medication-Assisted Treatment (MOUD),” outlines the roles of FDA-approved medications, behavioral therapy, and clinical monitoring, and clarifies terminology that patients and families may encounter when evaluating addiction treatment.

The publication coincides with Everwell Recovery’s inclusion of medications for opioid use disorder, or MOUD, within its Mission Viejo treatment model in Orange County. The organization’s published clinical information describes medically supervised detoxification, residential treatment, individual and group therapy, family involvement, trauma-informed care and structured aftercare planning, with medication support incorporated when clinically indicated.

The new resource addresses an important distinction between Medication-Assisted Treatment (MAT) and MOUD. MAT is a broader, long-used term describing the combination of medication with counseling and behavioral therapies for substance use disorders. MOUD is more specific and refers to medications used to treat opioid use disorder. The Substance Abuse and Mental Health Services Administration identifies methadone, buprenorphine, and naltrexone as FDA-approved medications for opioid use disorder. SAMHSA also uses the separate term medications for alcohol use disorder, or MAUD, for treatments such as acamprosate, disulfiram and naltrexone.

This distinction reflects an ongoing shift toward terminology that identifies medication as a direct component of evidence-based opioid treatment rather than an auxiliary service. SAMHSA’s 2026 guidance notes that the use of medications for opioid use disorder is commonly referred to as either MAT or MOUD. Everwell’s resource retains MAT terminology for familiarity while explaining MOUD as the more specific description for opioid-focused medication treatment.

Clinical evidence supports the role of these medications. The National Institute on Drug Abuse identifies medication as a standard component of care for opioid use disorder. It reports that approved medications can reduce opioid use, help patients remain in treatment, and lower the risk of overdose death. Medication selection and duration should be determined through professional assessment, patient preferences, medical history and treatment response.

Everwell Recovery’s published MOUD information describes the use of buprenorphine and naltrexone when clinically appropriate. Acamprosate is also identified within its medication services for alcohol use disorder. Medication is provided alongside counseling and behavioral treatment rather than as a stand-alone approach, and treatment plans may change according to each patient’s clinical progress.

The Mission Viejo program provides medically supervised withdrawal management and residential treatment in a structured setting near Lake Mission Viejo. Published clinical services include cognitive behavioral therapy, dialectical behavior therapy, motivational interviewing, trauma-informed treatment, family work, and relapse-prevention planning. Everwell Recovery is licensed by the California Department of Health Care Services, according to its admissions information.

For patients comparing residential or inpatient drug rehab programs, the availability of MOUD can be an important clinical consideration when opioid use disorder is present. The appropriate medication, residential setting, and length of treatment depend on assessment rather than on a standardized protocol. Patients may also require continuing behavioral health care after residential treatment.

The resource places MOUD within that broader continuum. Outpatient drug rehab, intensive outpatient drug rehab (IOP), and partial hospitalization drug rehab (PHP) represent treatment levels that patients may encounter after stabilization or residential care, depending on clinical needs and local availability. Everwell’s published programs currently emphasize detoxification, residential treatment, and structured aftercare planning rather than presenting IOP or PHP as on-site levels of care.

That distinction may be useful for people comparing what are described online as the best drug rehab centers or searching for a luxury drug rehab near them. Facility environment and amenities can influence comfort, but clinical capabilities such as withdrawal management, evidence-based therapy, medication access, qualified staffing and discharge planning provide more substantive measures when evaluating treatment.

Everwell Recovery’s Mission Viejo setting includes private residential care, chef-prepared meals, yoga, sound-based wellness activities and access to outdoor spaces near Lake Mission Viejo. These features are presented alongside, rather than in place of, clinical services such as detoxification, therapy and MOUD.

Through the new resource and the addition of MOUD within its Orange County treatment model, Everwell Recovery provides patients and families with clearer information about medication-based addiction treatment. The publication also helps distinguish MAT from MOUD and explains how medication, behavioral therapy, and residential care may be coordinated as part of an individualized recovery plan.

###

For more information about Everwell Recovery, contact the company here:

Everwell Recovery
Rojina Javanmardi
(949) 735-1025
info@everwellrecoveryoc.com
26841 Salinas Ln, Mission Viejo, CA 92691